Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation

被引:0
|
作者
Caraceni, P
Pertosa, AM
Domenicali, M
Cavalieri, B
Perrelli, MG
Principe, A
Cutrin, JC
Croci, T
Bernardi, M
机构
[1] Univ Bologna, Bologna, Italy
[2] Univ Turin, Turin, Italy
[3] Sanofi Synthelabo Res Labs, Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:698A / 698A
页数:1
相关论文
共 50 条
  • [1] Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist
    Hirst, RA
    Almond, SL
    Lambert, DG
    [J]. NEUROSCIENCE LETTERS, 1996, 220 (02) : 101 - 104
  • [2] Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716
    Terranova, JP
    Storme, JJ
    Lafon, N
    Perio, A
    RinaldiCarmona, M
    LeFur, G
    Soubrie, P
    [J]. PSYCHOPHARMACOLOGY, 1996, 126 (02) : 165 - 172
  • [3] Rapid tolerance to the intestinal prokinetic effect of cannabinoid CB1 receptor antagonist, SR 141716 (Rimonabant)
    Carai, MAM
    Colombo, G
    Gessa, GL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 494 (2-3) : 221 - 224
  • [4] Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A
    Kojima, Midori
    Kato, Naoto
    Hirano, Daisuke
    Ochi, Takashi
    Nii, Aisuke
    Shinjo, Katsuhiro
    Eda, Hiroyuki
    [J]. HEPATOLOGY RESEARCH, 2009, 39 (04) : 408 - 414
  • [5] Inverse agonist effects of the cannabinoid CB1 receptor antagonist SR141716A in rat brain.
    Sim-Selley, LJ
    Brunk, LK
    Selley, DE
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1447 - A1447
  • [6] The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus
    Tzavara, ET
    Perry, KW
    Rodriguez, DE
    Bymaster, FP
    Nomikos, GG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 426 (03) : R3 - R4
  • [7] Role of the cannabinoid cb1 receptor antagonist sr 141716a in relapse to heroin seeking
    Fattore, L
    Cossu, G
    Spano, MS
    Deiana, S
    Fadda, R
    Fratta, W
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S37 - S37
  • [8] Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
    Mansbach, RS
    Rovetti, CC
    Winston, EN
    Lowe, JA
    [J]. PSYCHOPHARMACOLOGY, 1996, 124 (04) : 315 - 322
  • [9] In vitro and in vivo metabolism of rimonabant (SR-141716), a cannabinoid (CB1) receptor antagonist
    Alberts, JJ
    Li, WY
    Behnia, K
    Zhang, LM
    Johnghar, S
    Humphreys, WG
    Zadjura, L
    Davis, CD
    Santone, KS
    Huang, S
    Liu, XH
    Kang, LY
    Carlson, KE
    Wu, ST
    Shu, YZ
    [J]. DRUG METABOLISM REVIEWS, 2003, 35 : 38 - 38
  • [10] Behavioral mechanisms underlying the hypophagic effect of the cannabinoid CB1 receptor antagonist SR 141716A in rats
    Schreiber, R
    De Vry, J
    [J]. BEHAVIOURAL PHARMACOLOGY, 2003, 14 : S48 - S48